InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-01 · accession 0001127602-24-026591 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-06 2024-11-04 DNA Coen Steven P. See remarks S - Sale+OE $7.58 -333 6,456 -5% -$2,524
DM 2024-11-06 2024-11-01 DNA Coen Steven P. See remarks M - OptEx — +743 6,633 +13% —
DM 2024-11-06 2024-11-01 DNA Coen Steven P. See remarks M - OptEx — -743 6,251 -11% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-11-04 S D 333 $7.58 6,456 D — —
2 Common Class A Common Stock 2024-11-01 M A 156 — 6,789 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
3 Common Class A Common Stock 2024-11-01 M A 587 — 6,633 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2024-11-01 M D 587 — 17,623 D — · — to — 587 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2024-11-01 M D 156 — 6,251 D — · — to — 156 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.